Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689788010 | Leuprolide acetate 11.25 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3689790011 | Leuprorelin acetate 11.25 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3782450014 | Product containing precisely leuprorelin acetate 11.25 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Is a | Product containing leuprorelin in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has presentation strength numerator value | 11.25 | false | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Has precise active ingredient | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Is a | Leuprorelin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Leuprorelin acetate 11.25 mg powder for solution for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR